http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108653235-B

Outgoing Links

Predicate Object
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50
filingDate 2015-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2021-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2021-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-108653235-B
titleOfInvention Preparation process of carbon-coated magnetic guiding drug carrier
abstract The invention discloses a preparation process of a carbon-coated magnetic guiding drug carrier, belonging to an interventional therapy carrier and being characterized in that: NaOH, FeCl 3 ·6H 2 O、FeCl 2 ·4H 2 The molar ratio of O is OH ‑ :Fe 3+ :Fe 2+ 8.0: 1.0-1.8: 1.0, firstly, adding pregelatinized starch into a sodium hydroxide solution, and stirring until the pregelatinized starch is completely dissolved; and ultrasonically mixing the mixture at the frequency of 200Hz, then dropwise adding a mixed iron solution into the gelatinized mixed solution, reacting the mixture in a high-temperature reaction kettle under an inert atmosphere, keeping the temperature at 180-240 ℃ for 6-10 hours, naturally cooling, washing and drying to obtain the carbon-coated ferroferric oxide. Compared with the prior art, the invention overcomes the defects of complex coating process, high production cost, unstable product performance and the like of the traditional magnetic particle carrier for targeted therapy.
priorityDate 2015-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24380
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527028
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14789
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559465
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453265332
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409060395
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11289
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID29936
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556970
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493516
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23925
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419525871
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559581
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546718
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14798
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452506218
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID947
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24826
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24458
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491185

Total number of triples: 37.